Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis
Rebecca Banerjee, Anatoly A. Starkov, M. Flint Beal, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2008) Vol. 1792, Iss. 7, pp. 651-663
Open Access | Times Cited: 252

Showing 26-50 of 252 citing articles:

A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease
Charleen T. Chu
Human Molecular Genetics (2010) Vol. 19, Iss. R1, pp. R28-R37
Open Access | Times Cited: 157
Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders
Swati Agarwal, Anuradha Yadav, Rajnish Kumar Chaturvedi
Biochemical and Biophysical Research Communications (2016) Vol. 483, Iss. 4, pp. 1166-1177
Closed Access | Times Cited: 156
Oxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury
Gavin C. Higgins, Philip M. Beart, Yea Seul Shin, et al.
Journal of Alzheimer s Disease (2010) Vol. 20, Iss. s2, pp. S453-S473
Open Access | Times Cited: 147
PGC-1α in aging and anti-aging interventions
Rozalyn M. Anderson, Tomas A. Prolla
Biochimica et Biophysica Acta (BBA) - General Subjects (2009) Vol. 1790, Iss. 10, pp. 1059-1066
Open Access | Times Cited: 146
Genetic deficiency of the mitochondrial protein PGAM5 causes a Parkinson’s-like movement disorder
Wei Lü, Senthilkumar S. Karuppagounder, Danielle A. Springer, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 145
TOM40 Mediates Mitochondrial Dysfunction Induced by α-Synuclein Accumulation in Parkinson’s Disease
Andreas Bender, Paula Desplats, Brian Spencer, et al.
PLoS ONE (2013) Vol. 8, Iss. 4, pp. e62277-e62277
Open Access | Times Cited: 144
Exploring the link between glucocerebrosidase mutations and parkinsonism
Wendy Westbroek, Ann Marie Gustafson, Ellen Sidransky
Trends in Molecular Medicine (2011) Vol. 17, Iss. 9, pp. 485-493
Open Access | Times Cited: 141
Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5′-triphosphate synthase activity*
André Miguel Japiassú, Ana Paula S. A. Santiago, Joana C. d’Avila, et al.
Critical Care Medicine (2011) Vol. 39, Iss. 5, pp. 1056-1063
Closed Access | Times Cited: 140
Evaluation of Markers of Oxidative Stress, Antioxidant Function and Astrocytic Proliferation in the Striatum and Frontal Cortex of Parkinson’s Disease Brains
Rajeswara Babu Mythri, C. Venkateshappa, G. Harish, et al.
Neurochemical Research (2011) Vol. 36, Iss. 8, pp. 1452-1463
Closed Access | Times Cited: 139
Mitochondrial dynamics in Parkinson's disease
Victor S. Van Laar, Sarah Berman
Experimental Neurology (2009) Vol. 218, Iss. 2, pp. 247-256
Open Access | Times Cited: 134
A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
Shams Tabrez, Nasimudeen R. Jabir, Shazi Shakil, et al.
CNS & Neurological Disorders - Drug Targets (2012) Vol. 11, Iss. 4, pp. 395-409
Open Access | Times Cited: 132
4-Hydroxynonenal Inhibits SIRT3 via Thiol-Specific Modification
Kristofer S. Fritz, James J. Galligan, Rebecca L. Smathers, et al.
Chemical Research in Toxicology (2011) Vol. 24, Iss. 5, pp. 651-662
Open Access | Times Cited: 121
Mutual exacerbation of peroxisome proliferator‐activated receptor γ coactivator 1α deregulation and α‐synuclein oligomerization
Judith Eschbach, Björn von Einem, Kathrin Müller, et al.
Annals of Neurology (2014) Vol. 77, Iss. 1, pp. 15-32
Open Access | Times Cited: 119
Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α‐synuclein
Nicola J. Rutherford, Brenda D. Moore, Todd E. Golde, et al.
Journal of Neurochemistry (2014) Vol. 131, Iss. 6, pp. 859-867
Closed Access | Times Cited: 117
Models of α-synuclein aggregation in Parkinson’s disease
Rosa M. Giráldez‐Pérez, Mónica Antolín‐Vallespín, María‐Dolores Muñoz, et al.
Acta Neuropathologica Communications (2014) Vol. 2, Iss. 1
Open Access | Times Cited: 115
Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1α in human dopaminergic neurons via Sirtuin-1
Johanna Mäkelä, Timofey V. Tselykh, Francesca Maiorana, et al.
SpringerPlus (2014) Vol. 3, Iss. 1
Open Access | Times Cited: 104
An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition
Andrea Terron, Anna Bal‐Price, Alicia Paini, et al.
Archives of Toxicology (2017) Vol. 92, Iss. 1, pp. 41-82
Open Access | Times Cited: 104
Early Life Stress, Depression And Parkinson’s Disease: A New Approach
Ernest Dallé, Musa V. Mabandla
Molecular Brain (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 101
The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson’s Disease
Minrui Weng, Xiaoji Xie, Chao Liu, et al.
Parkinson s Disease (2018) Vol. 2018, pp. 1-9
Open Access | Times Cited: 101
1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy
Wooyoung Jang, Hee‐Ju Kim, Huan Li, et al.
Biochemical and Biophysical Research Communications (2014) Vol. 451, Iss. 1, pp. 142-147
Closed Access | Times Cited: 100
Cellular Mechanisms of Oxidative Stress and Action in Melanoma
Mario Venza, Maria Visalli, Concetta Beninati, et al.
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 98
Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson’s Disease
E. Maruthi Prasad, Shih‐Ya Hung
Antioxidants (2020) Vol. 9, Iss. 10, pp. 1007-1007
Open Access | Times Cited: 87
Current perspective of mitochondrial biology in Parkinson's disease
Navneet Ammal Kaidery, Bobby Thomas
Neurochemistry International (2018) Vol. 117, pp. 91-113
Open Access | Times Cited: 84
Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases
Chiara Martinelli, Carlotta Pucci, Matteo Battaglini, et al.
Advanced Healthcare Materials (2019) Vol. 9, Iss. 3
Open Access | Times Cited: 80
Parkinson’s disease protein DJ-1 regulates ATP synthase protein components to increase neuronal process outgrowth
Rongmin Chen, Hana Park, Nelli Mnatsakanyan, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 79

Scroll to top